This content is created or selected by the Healthgrades editorial team and is funded by an advertising sponsor. The content is subject to the Healthgrades medical review process for accuracy, balance and objectivity. The content is not edited or otherwise influenced by the advertisers appearing on this page except with the possible suggestion of the broad topic area. For more information, read the Healthgrades advertising policy.
Significant progress has been made in the treatment of rheumatoid arthritis (RA) due to a new class of medications called biologics. Biologics work by blocking the immune response that leads to the painful symptoms of RA. They are also effective in about 2/3 of patients who use them.